Treatment of pruritus associated with systemic disorders in the elderly: A review of the role of new therapies

Drugs and Aging

Volumn 20, Issue 3, 2003, Pages 197-208

  Lonsdale Eccles, Ann ^a   Carmichael, Andrew J ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANTIHISTAMINIC AGENT; CAPSAICIN; COLESTIPOL; COLESTYRAMINE; CYCLOSPORIN A; FLUMECINOL; LIDOCAINE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE ANTAGONIST; PHENOBARBITAL; PROPOFOL; RIFAMPICIN; S ADENOSYLMETHIONINE; THALIDOMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; URSODEOXYCHOLIC ACID;

AGED; AGING; BIRTH DEFECT; BRAIN INFARCTION; CHOLESTASIS; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DROWSINESS; DRUG METABOLISM; HEMATOLOGIC MALIGNANCY; HUMAN; IRON DEFICIENCY; KIDNEY DISEASE; LIVER CELL; LIVER FUNCTION; LIVER TRANSPLANTATION; PARANEOPLASTIC SYNDROME; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; REVIEW; SIDE EFFECT; SYSTEMIC DISEASE; THYROID DISEASE; ULTRAVIOLET B RADIATION;

AGED; ANIMALS; HUMANS; PRURITUS;

EID: 0037288838     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200320030-00004     Document Type: Review

References (154)

1. Lidstone V, Thorns A. Pruritus in cancer patients. Cancer Treat Rev 2001; 27 (5): 305-12
2. Greaves MW. Itching - research has barely scratched the surface. N Engl J Med 1992; 326 (15): 1016-7
3. Denman ST. A review of pruritus. J Am Acad Dermatol 1986; 14 (3): 375-92
4. Potts RO, Buras Jr EM, Chrisman Jr DA. Changes with age in the moisture content of human skin. J Invest Dermatol 1984; 82 (1): 97-100
5. Kantor GR, Lookingbill DP. Generalized pruritus and systemic disease. J Am Acad Dermatol 1983; 9 (3): 375-82
6. Dykes PJ, Marks R. An appraisal of the methods used in the assessment of atrophy from topical corticosteroids. Br J Dermatol 1979; 101 (5): 599-609
7. Reitamo S, Rissanen J, Remitz A, et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998; 111 (3): 396-8
8. Aioardi C, Dost FH. Menthol and menthol-containing external remedies. International symposium on menthol and menthol-containing external remedies; use, mode of effect and tolerance in children. In: Do Fh, Leiber B, editors. International Symposium; 1966 April; Paris: Stuttgart, George Thieme Verlog, 1967
9. Bromm B, Scharein E, Darsow U, et al. Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett 1995; 187 (3): 157-60
10. Hagermark O, Wahlgren CF. Treatment of itch. Semin Dermatol 1995; 14 (4): 320-5
11. Smith EB, King CA, Baker MD. Crotamiton lotion in pruritus. Int J Dermatol 1984; 23 (10): 684-5
12. Doxepin cream for eczema? Drug Ther Bull 2000; 38 (4): 31-2
13. Greiding L, Moreno P. Doxepin incorporated into a dermatologic cream: an assessment of both doxepin antipruritic action and doxepin action as an inhibitor of papules, in allergen and histamine-caused pruritus. Allergol Immunopathol (Madr) 1999; 27 (5): 265-70
14. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995; 131 (12): 1403-8
15. Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 1994; 31 (4): 613-6
16. Tonnesen MG. Pruritus. In: Fitzpatrick TB, Eisen AZ, Wolff K, editors. Dermatology in general medicine. 2nd ed. New York: McGraw-Hill, 1979: 32-4
17. Isaacs NJ, Ertel NH. Urticaria and pruritus: uncommon manifestations of hyperthyroidism. J Allergy Clin Immunol 1971; 48 (2): 73-81
18. Barnes HM, Sarkany I, Calnan CD. Pruritus and thyrotoxicosis. Trans St Johns Hosp Dermatol Soc 1974; 60 (1): 59-62
19. Carmichael AJ, McHugh MM, Martin AM, et al. Serological markers of renal itch in patients receiving long term haemodialysis. Br Med J (Clin Res Ed) 1988; 296 (6636): 1575
20. Blachley JD, Blankenship DM, Menter A, et al. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis 1985; 5 (5): 237-41
21. Winkelmann RK. Pharmacologic control of pruritus. Med Clin North Am 1982; 66 (5): 1119-33
22. Kleeman CR, Massry SG, Popovtzer MM, et al. The disappearance of intractable pruritus after parathyroidectomy in uremic patients with secondary hyperparathyroidism. Trans Assoc Am Physicians 1968; 81: 203-12
23. Massry SG, Popovtzer MM, Coburn JW, et al. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med 1968; 279 (13): 697-700
24. Neilly JB, Martin A, Simpson N, et al. Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control. Diabetes Care 1986; 9: 273-5
25. Staubli M. Pruritus - a little known iron-deficiency symptom [in German]. Schweiz Med Wochenschr 1981; 111 (38): 1394-8
26. Oral iron. In: Mehta DK, editor. British National Formulary. 43th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2002: 437
27. Gilchrest BA. Pruritus: pathogenesis, therapy, and significance in systemic disease states. Arch Intern Med 1982; 142 (1): 101-5
28. Wasserman LR. The treatment of polycythemia vera. Semin Hematol 1976; 13 (1): 57-78
29. Archer CB, Camp RD, Greaves MW. Polycythaemia vera can present with aquagenic pruritus. Lancet 1988; 1 (8600): 1451
30. Muller EW, de Wolf JT, Egger R, et al. Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera. Br J Haematol 1995; 89 (2): 313-8
31. Salem HH, Van der Weyden MB, Young IF, et al. Pruritus and severe iron deficiency in polycythaemia vera. Br Med J (Clin Res Ed) 1982; 285 (6335): 91-2
32. Fjellner B, Hagermark O. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol 1979; 59 (6): 505-12
33. Weick JK, Donovan PB, Najean Y, et al. The use of cimetidine for the treatment of pruritus in polycythemia vera. Arch Intern Med 1982; 142 (2): 241-2
34. Kolodny L, Horstman LL, Sevin BU, et al. Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases. Am J Hematol 1996; 51 (2): 112-6
35. Randi ML, Luzzatto G, Fabris F. Danazol in refractory pruritus of myeloproliferative disorders. Am J Hematol 1997; 54 (2): 172-3
36. Chanarin I, Szur L. Relief of intractable pruritus in polycythaemia rubra vera with cholestyramine [letter]. Br J Haematol 1975; 29 (4): 669-70
37. Steinman HK, Greaves MW. Aquagenic pruritus. J Am Acad Dermatol 1985; 13 (1): 91-6
38. Jeanmougin M, Rain JD, Najean Y. Efficacy of photochemotherapy on severe pruritus in polycythemia vera. Ann Hematol 1996; 73 (2): 91-3
39. Baldo A, Monfrecola G. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera. Br J Dermatol 2002; 147 (5): 979-81
40. Gaudin P, Rozand Y, Fauconnier J, et al. Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma: a national survey of one hundred forty-six patients. Rev Rhum Engl Ed 1995; 62 (5): 365-75
41. Alexander LL. Pruritus and Hodgkin's disease. JAMA 1979; 241 (24): 2598-9
42. Feiner AS, Mahmood T, Wallner SF. Prognostic importance of pruritus in Hodgkin's disease. JAMA 1978; 240 (25): 2738-40
43. Gobbi PG, Attardo-Parrinello G, Lattanzio G, et al. Severe pruritus should be a B-symptom in Hodgkin's disease. Cancer 1983; 51 (10): 1934-6
44. Gobbi PG, Cavalli C, Gendarini A, et al. Reevaluation of prognostic significance of symptoms in Hodgkin's disease. Cancer 1985; 56 (12): 2874-80
45. Young Jr AW, Sweeney EW, David DS, et al. Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med 1973; 73 (22): 2670-4
46. Gilchrest BA, Stern RS, Steinman TI, et al. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 1982; 118 (3): 154-6
47. Bencini PL, Montagnino G, Citterio A, et al. Cutaneous abnormalities in uremic patients. Nephron 1985; 40 (3): 316-21
48. Southi P, Commens C. Pruritus in dialysis patients. Med J Aust 1987; 146 (7): 397, 400
49. Matsumoto M, Ichimaru K, Horie A. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol 1985; 23 (6): 285-8
50. Stahle-Backdahl M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol Suppl 1989; 145: 1-38
51. Ponticelli C, Bencini PL. Uremic pruritus: a review. Nephron 1992; 60 (1): 1-5
52. Duo LJ. Electrical needle therapy of uremic pruritus. Nephron 1987; 47 (3): 179-83
53. Yatzidis H, Digenis P, Tountas C. Heparin treatment of uremic itching. JAMA 1972; 222 (9): 1183
54. Fishman SM, Caneris OA, Stojanovic MP, et al. Intravenous lidocaine for treatment-resistant pruritus. Am J Med 1997; 102 (6): 584-5
55. Watson WC. Intravenous lignocaine for relief of intractable itch. Lancet 1973; 1 (7796): 211
56. Tapia L, Cheigh JS, David DS, et al. Pruritus in dialysis patients treated with parenteral lidocaine. N Engl J Med 1977; 296 (5): 261-2
57. Masi CM, Cohen EP. Dialysis efficacy and itching in renal failure. Nephron 1992; 62 (3): 257-61
58. Hiroshige K, Kabashima N, Takasugi M, et al. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995; 25 (3): 413-9
59. Kyriazis J, Glotsos J. Dialysate calcium concentration of
60. Schwartz IF, Iaina A. Uraemic pruritus. Nephrol Dial Transplant 1999; 14 (4): 834-9
61. Pauli-Magnus C, Mikus G, Alscher DM, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 2000; 11 (3): 514-9
62. Morton CA, Lafferty M, Hau C, et al. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant 1996; 11 (10): 2031-6
63. De Marchi S, Cecchin E, Villalta D, et al. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 1992; 326 (15): 969-74
64. Balaskas EV, Uldall RP. Erythropoietin treatment does not improve uremic pruritus. Petit Dial Int 1992; 12 (3): 330-1
65. Tan JK, Haberman HF, Coldman AJ. Identifying effective treatments for uremic pruritus. J Am Acad Dermatol 1991; 25 (5 Pt 1): 811-8
66. Gilchrest BA, Rowe JW, Brown RS, et al. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med 1979; 91 (1): 17-21
67. Slaper H, Schothorst AA, van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatol 1986; 3 (5): 271-83
68. Taylor R, Taylor AE, Diffey BL, et al. A placebo-controlled trial of UV-A phototherapy for the treatment of uraemic pruritus. Nephron 1983; 33 (1): 14-6
69. Simpson NB, Davison AM. Ultraviolet phototherapy for uraemic pruritus. Lancet 1981; 1 (8223): 781
70. Spiro JG, Scott S, MacMillan J, et al. Treatment of uremic pruritus with blue light. Photodermatol 1985; 2 (5): 319-21
71. Silverberg DS, Iaina A, Reisin E, et al. Cholestyramine in uraemic pruritus. Br Med J 1977; 1 (6063): 752-3
72. van Leusen R, Kutsch Lojenga JC, Ruben A. Is cholestyramine helpful in uraemic pruritus? Br Med J 1978; 1 (6117): 918-9
73. Wrong OM. Cholestyramine in uraemic pruritus. Br Med J 1977; 1 (6077): 1662
74. Pederson JA, Matter BJ, Czerwinski AW, et al. Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal. Ann Intern Med 1980; 93 (3): 446-8
75. Giovannetti S, Barsotti G, Cupisti A, et al. Oral activated charcoal in patients with uremic pruritus. Nephron 1995; 70 (2): 193-6
76. Mettang T, Fischer FP, Dollenbacher U, et al. Uraemic pruritus is not related to beta-endorphin serum levels in haemodialysis patients. Nephrol Dial Transplant 1998; 13 (1): 231-2
77. Hwang JC, Hsu KT, Tsai HC, et al. Serum endorphin levels in uremic patients under maintenance hemodialysis. Taiwan Yi Xue Hui Za Zhi 1989; 88 (4): 360-5
78. Peer G, Kivity S, Agami O, et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996; 348 (9041): 1552-4
79. Kerr PG, Argiles A, Mion C. Whole blood serotonin levels are markedly elevated in patients on dialytic therapy. Am J Nephrol 1992; 12 (1-2): 14-8
80. Balaskas EV, Bamihas GI, Karamouzis M, et al. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 1998; 78 (4): 395-402
81. Ashmore SD, Jones CH, Newstead CG, et al. Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis 2000; 35 (5): 827-31
82. Murphy M, Reaich D, Finn P, et al. A randomised, placebo-controlled, double-blind trial of ondansetron in renal itch. Br J Dermatol 2001; 145: 34-5
83. Breneman DL, Cardone JS, Blumsack RF, et al. Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 1992; 26 (1): 91-4
84. Cho YL, Liu HN, Huang TP, et al. Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 1997; 36 (4): 538-43
85. Tarng DC, Cho YL, Liu HN, et al. Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron 1996; 72 (4): 617-22
86. Neiman RS, Bischel MD, Lukes RJ. Uraemia and mast-cell proliferation. Lancet 1972; 1 (7757): 959
87. Stockenhuber F, Kurz RW, Sertl K, et al. Increased plasma histamine levels in uraemic pruritus. Clin Sci (Colch) 1990; 79 (5): 477-82
88. Mettang T, Fritz P, Weber J, et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 1990; 34 (3): 136-41
89. Klein LR, Klein JB, Hanno R, et al. Cutaneous mast cell quantity in pruritic and nonpruritic hemodialysis patients. Int J Dermatol 1988; 27 (8): 557-9
90. Silva SR, Viana PC, Lugon NV, et al. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 1994; 67 (3): 270-3
91. Powell RJ, Gardner-Medwin JM. Guideline for the clinical use and dispensing of thalidomide. Postgrad Med J 1994; 70 (830): 901-4
92. Ghent CN. Cholestatic pruritus. In: Bernhard JD, editor. Itch, mechanisms, and management of pruritus. New York: McGraw-Hill, 1994: 229-42
93. Ahrens EH, Payne MA, Kunkel HG, et al. Primary biliary cirrhosis. Medicine 1950; 29: 299-364
94. Bartholomew TC, Summerfield JA, Billing BH, et al. Bile acid profiles of human serum and skin interstitial fluid and their relationship to pruritus studied by gas chromatography-mass spectrometry. Clin Sci (Colch) 1982; 63 (1): 65-73
95. Jones EA, Bergasa NV. The pruritus of cholestasis. Hepatology 1999; 29 (4): 1003-6
96. Rupp N. Indications and results of percutaneous transhepatic bile-duct drainage [in German]. Chirurg 1979; 50 (4): 233-8
97. Bergasa NV, Jones EA. Management of the pruritus of cholestasis: potential role of opiate antagonists. Am J Gastroenterol 1991; 86 (10): 1404-12
98. Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis: a double-blind, placebo-controlled study. Gastroenterology 1990; 99 (1): 211-5
99. Metze D, Reimann S, Beissert S, et al. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999; 41 (4): 533-9
100. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ 1988; 297 (6662): 1501-4
101. Bergasa NV, Ailing DW, Vergalla J, et al. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J Hepatol 1994; 20 (1): 85-90
102. Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992; 102 (2): 544-9
103. Bergasa NV, Ailing DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial. Ann Intern Med 1995; 123 (3): 161-7
104. Bergasa NV, Schmitt JM, Talbot TL, et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998; 27 (3): 679-84
105. Bergasa NV, Alling DW, Talbot TL, et al. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 1999; 41 (3 Pt 1): 431-4
106. Wolfhagen FH, Sternieri E, Hop WC, et al. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997; 113 (4): 1264-9
107. Carson KL, Tran TT, Cotton P, et al. Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease. Am J Gastroenterol 1996; 91 (5): 1022-3
108. Jones EA, Dekker LR. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Gastroenterology 2000; 118 (2): 431-2
109. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 1988; 94 (2): 488-93
110. Bloomer JR, Boyer JL. Phenobarbital effects in cholestatic liver diseases. Ann Intern Med 1975; 82 (3): 310-7
111. Turner IB, Rawlins MD, Wood P, et al. Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis. Aliment Pharmacol Ther 1994; 8 (3): 337-42
112. Hoensch HP, Balzer K, Dylewizc P, et al. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur J Clin Pharmacol 1985; 28 (4): 475-7
113. Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990; 98 (4): 1013-6
114. Woolf GM, Reynolds TB. Failure of rifampin to relieve pruritus in chronic liver disease. J Clin Gastroenterol 1990; 12 (2): 174-7
115. Bachs L, Pares A, Elena M, et al. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet 1989; 1 (8638): 574-6
116. Kreek MJ, Garfield JW, Gutjahr CL, et al. Rifampin-induced methadone withdrawal. N Engl J Med 1976; 294 (20): 1104-6
117. Prince MI, Jones DE. Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J 2000; 76 (894): 199-206
118. Schworer H, Hartmann H, Ramadori G. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain 1995; 61 (1): 33-7
119. Muller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998; 10 (10): 865-70
120. Larijani GE, Goldberg ME, Rogers KH. Treatment of opioidinduced pruritus with ondansetron: report of four patients. Pharmacotherapy 1996; 16 (5): 958-60
121. Crighton IM, Hobbs GJ, Reid MF. Ondansetron for the treatment of pruritus after spinal opioids. Anaesthesia 1996; 51 (2): 199-200
122. Borgeat A, Wilder-Smith OH, Mentha G. Subhypnotic doses of propofol relieve pruritus associated with liver disease. Gastroenterology 1993; 104 (1): 244-7
123. Borgeat A, Wilder-Smith OH, Saiah M, et al. Subhypnotic doses of propofol relieve pruritus induced by epidural and intrathecal morphine. Anesthesiology 1992; 76 (4): 510-2
124. Hanid MA, Levi AJ. Phototherapy for pruritus in primary biliary cirrhosis. Lancet 1980; 2 (8193): 530
125. Walt RP, Daneshmend TK, Fellows IW, et al. Effect of stanozolol on itching in primary biliary cirrhosis. Br Med J (Clin Res Ed) 1988; 296 (6622): 607
126. Lloyd-Thomas HGL, Sherlock S. Testosterone therapy for the pruritus of obstructive jaundice. BMJ 1952; 2: 1289-91
127. Whitmore SE. Treatment of hepatobiliary pruritus. J Am Acad Dermatol 1997; 36 (2 Pt 1): 279
128. Poupon R, Chretien Y, Poupon RE, et al. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; 1 (8537): 834-6
129. Matsuzaki Y, Tanaka N, Osuga T, et al. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. Am J Gastroenterol 1990; 85 (1): 15-23
130. Koeppel MC, Bramont C, Ceccaldi M, et al. Paroxysmal pruritus and multiple sclerosis. Br J Dermatol 1993; 129 (5): 597-8
131. Kimyai-Asadi A, Nousari HC, Kimyai-Asadi T, et al. Poststroke pruritus. Stroke 1999; 30 (3): 692-3
132. Osterman PO. Paroxysmal itching in multiple sclerosis. Br J Dermatol 1976; 95 (5): 555-8
133. Canavero S, Bonicalzi V, Massa-Micon B. Central neurogenic pruritus: a literature review. Acta Neurol Belg 1997; 97 (4): 244-7
134. Massey EW. Unilateral neurogenic pruritus following stroke. Stroke 1984; 15 (5): 901-3
135. Bernhard JD. Neurogenic pruritus and strange skin sensations. In: Bernhard JD, editor. Itch: mechanisms and management of pruritus. 1st ed. New York (NY): McGraw-Hill, 1994
136. Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage 1998; 16 (2): 121-4
137. Feuerman EJ. Sjogren's syndrome presenting as recalcitrant generalized pruritus. Some remarks about its relation to collagen diseases and the connection of rheumatoid arthritis with the Sicca syndrome. Dermatologica 1968; 137 (2): 74-86
138. Kovacs SO, Kovacs SC. Dermatomyositis. J Am Acad Dermatol 1998; 39 (6): 899-920
139. Thaipisuttikul Y. Pruritic skin diseases in the elderly. J Dermatol 1998; 25 (3): 153-7
140. Jacobsen E, Billings JK, Frantz RA, et al. Age-related changes in sebaceous wax ester secretion rates in men and women. J Invest Dermatol 1985; 85 (5): 483-5
141. Yamamoto A, Serizawa S, Ito M, et al. Effect of aging on sebaceous gland activity and on the fatty acid composition of wax esters. J Invest Dermatol 1987; 89 (5): 507-12
142. Long CC, Marks R. Stratum corneum changes in patients with senile pruritus. J Am Acad Dermatol 1992; 27 (4): 560-4
143. Hunter JA. Seventh age itch. Br Med J (Clin Res Ed) 1985; 291 (6499): 842
144. Waisman M. A clinical look at the aging skin. Postgrad Med 1979; 66 (1): 87-93, 96
145. Bernhard JD. Phantom itch, pseudophantom itch, and senile pruritus. Int J Dermatol 1992; 31 (12): 856-7
146. Polenghi M, Colombo MD, Barcella ML, et al. A thioridazine-dihydroergotoxine combination in the treatment of senile pruritus [in Italian]. G Ital Dermatol Venereol 1989; 124 (9): LI-LIII
147. Paul R, Jansen CT. Itch and malignancy prognosis in generalized pruritus: a 6-year follow-up of 125 patients. J Am Acad Dermatol 1987; 16 (6): 1179-82
148. Teofoli P, De Pita O, Frezzolini A, et al. Antipruritic effect of oral cyclosporin A in essential senile pruritus. Acta Derm Venereol 1998; 78 (3): 232
149. Ungvari G, Vladar K. Pimozide treatment for delusion of infestation. Act Nerv Super (Praha) 1986; 28 (2): 103-7
150. Munro A. Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis: a description of four cases successfully treated with pimozide. Arch Dermatol 1978; 114 (6): 940-3
151. Elmer KB, George RM, Peterson K. Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Am Acad Dermatol 2000; 43 (4): 683-6
152. Fawcett RG. Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis. J Clin Psychiatry 2002; 63 (2): 169
153. Weintraub E, Robinson C. A case of monosymptomatic hypochondriacal psychosis treated with olanzapine. Ann Clin Psychiatry 2000; 12 (4): 247-9
154. Fried RG. Evaluation and treatment of "psychogenic" pruritus and self-excoriation. J Am Acad Dermatol 1994; 30 (6): 993-9